MSA Safety Incorporated (NYSE:MSA) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Operator: Good day, and welcome to the MSA Safety Fourth Quarter and Full ...
Brokerages Set MSA Safety Incorporated (NYSE:MSA) Price Target at $202.50
Shares of MSA Safety Incorporated (NYSE:MSA – Get Free Report) have earned a consensus rating of “Buy” from the five brokerages that are presently covering the company, MarketBeat.com reports. One ...
MSA Safety outlines low single-digit organic sales growth for 2025 amid dynamic environment
Discover MSA Safety's Q4 2024 earnings insights, including strong margin growth, connected device innovations, and 2025 strategies amid dynamic ...
MSA Safety sees 2025 revenue in low-single digits from 2024 revenue of $1.83B
Consensus for 2025 revenue is $1.87B. Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a ...
H. Lundbeck A/S: Lundbeck's potential treatment amlenetug for Multiple System Atrophy receives Fast Track Designation from the FDA
The FDA has granted Fast Track Designation to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).
PharmiWeb3d
Lundbeck’s potential treatment amlenetug for Multiple System Atrophy receives Fast Track Designation from the FDA
The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). Lundbeck has recently initiated ...